Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.

However, there was limited clinical evidence comparing their impact on COPD outcomes in patients with type 2 diabetes.” “Researchers continue studying GLP-1 medications beyond diabetes and ...

"This may inform prescribing of glucose-lowering medications among patients with T2D and active COPD," making SGLT2 and GLP-1 drugs preferable over DPP-4 inhibitors for these patients, the group ...

The most common and noticeable ... to breathe and feel better. Your treatment goals for COPD may include: relieving your symptoms slowing the progress of the disease improving your exercise ...

Study objectives: To identify the predictors of medication adherence in patients with COPD and contrast the health beliefs, experiences, and behaviors of COPD patients self-reporting good ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

These men and women are fighting a common enemy: COPD – Chronic Obstructive Pulmonary Disease. Their lungs don't work normally…every breath taken can be a struggle. What do they believe to be ...

This may inform prescribing of glucose-lowering medications among patients with type 2 diabetes and active COPD.

Several features of COPD (dyspnea, air hunger, functional decline, and the possibility of mechanical ventilation) commonly ... impact on future treatment. Thus direct patient-physician discussions ...

Professor David Denning evaluates timely and accurate diagnosis of Aspergillus infection and the clinical spectrum of ...